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1147-211 Determinants of Muscular Damage With External 
Cardioversion of Atrial Fibrillation: Results of a 
Randomized Trial Comparing Biphasic With 
Monophasic Shock
Stefano Fumagalli, Lorenzo Boncinelli, Nadia Boni, Margherita Padeletti, Adriana Virgillo, 
Caterina Franceschini, Massimo Aglietti, Niccolò Marchionni, Institute of Gerontology, 
Florence, Italy
Background. We want to compare the effects on muscular damage of the monophasic
shock (M) with that of the new biphasic one (B) in patients (pts) undergoing external car-
dioversion (ECV) of atrial fibrillation (AF).
Methods. All the pts admitted for ECV (n=171, age: 74±9, men: 68%) between 3/2001
and 6/2003 were randomized to B (Multipulse Biowave) or M. To stop AF, energy was
delivered if necessary with stepwise increments until the highest value; in case of failure,
pts crossed to ECV with the other waveform. Blood samples were collected to determine
indexes of muscular damage.
Results. After randomization, 90 pts were assigned to B and 81 to M. No differences
existed between the two waveforms in efficacy (B: 88 vs M: 90%, p=.813). The energy
delivered with the effective shock was lower with B (127±41 vs 229±99 J, p=.001), such
as the total amount of delivered energy by weight (3±2 vs 4±3 J/Kg, p=.026). After ECV,
indexes of muscular damage were altered only in pts treated with M (CPK - M: +200±75
vs B: -21±11 UI/L, p=.002; Myoglobin - M: +239±85 vs B: -2±11 ng/ml, p=.001). Multivari-
ate models showed that both the increases for CPK and Myoglobin were positively
related not only to the total amount of energy delivered (p=.001 in both cases) but also to
the use of M (p=.038 and p=.041, respectively). No associations were noted with cardiac
and systemic diseases and with variables related to AF.
Conclusion. B has an efficacy comparable to M, but it is safer, because shocks need
lower energy and so lower currents go through the patients.
1147-212 Accuracy of Arrhythmia Discrimination Algorithms: 
First Results From a Prospective, Randomized Trial of 
Single Versus Dual Chamber Implantable Cardioverter 
Defibrillators (PINAPP)
Dominic A. Theuns, Peter J. Klootwijk, Luc J. Jordaens, Erasmus MC, Rotterdam, The 
Netherlands
Background: Accurate discrimination between supraventricular tachycardias (SVT) and
ventricular tachycardias (VT) is an important clinical issue. The addition of atrial informa-
tion in dual chamber devices may theoretically improve the accuracy of arrhythmia dis-
crimination. The superiority of enhanced discrimination algorithms in dual chamber ICDs
has still not been proven.
Methods: PINAPP is a prospective, randomized trial designed to investigate the accu-
racy of single and dual chamber discrimination algorithms. All pts met Class I/II (AHA/
ACC/ESC) for ICD implantation and had no indication for bradycardia pacing. Pts with
permanent atrial fibrillation or an indication for resynchronization therapy were excluded.
All patients (pts) received a dual chamber ICD (Prizm DR, Guidant; Tachos DR,
Biotronik) and randomized to programmed single chamber detection (onset 16%, stability
40 ms) or dual chamber detection (onset 16%, stability 40 ms, Afib threshold 300 ms,
V>A or SMART).
Results: 60 pts (47 male, 59 years, LVEF 30%, coronary artery disease 78%) were
included, 29 pts single chamber and 31 pts dual chamber. 496 episodes (31 pts) were
documented by stored electrograms. A total of 230 SVTs (65 AF; 10 AFl; 78 AT; 77 ST)
and 266 VTs were analyzed. There was no significant difference in accuracy between
single and dual chamber arrhythmia discrimination (83% vs 84%, P=NS). The majority of
inappropriate detection was observed in antegradely 1:1 AV conducted SVTs (44/97 sin-
gle vs 28/58 dual, P=NS). Dual chamber detection detected significantly more often AT
as VT (14/42 single vs 21/22 dual, P = 0,05). There was no significant difference between
single and dual chamber detection of AF.
Conclusion: The preliminary data of the PINAPP trial demonstrate no difference in accu-
racy in arrhythmia discrimination between single and dual chamber detection. SVTs with
a stable ventricular response remain a problem for arrhythmia discrimination in both sin-
gle and dual chamber ICDs. Detection enhancements in dual chamber devices can act
as an accelerator for inappropriate therapy.
1147-213 Underutilization of Implantable Cardioverter-
Defibrillators in Survivors of Sudden Cardiac Death: 
Discrepancies by Sex, Race, and Hospital Size
Andrew Voigt, Samir Saba, University of Pittsburgh, Pittsburgh, PA
Background: Sudden cardiac death (SCD) is a class I indication for implantable cardio-
verter-defibrillator (ICD) therapy. We analyzed the incidence of ICD implantation in survi-
vors of SCD in the United States from 1996 through 2001.
Methods: We searched a representative sample of all hospital discharges for patients
admitted with the primary diagnosis of ventricular fibrillation, ventricular flutter, or cardiac
arrest who survived to hospital discharge. Patients with a concomitant diagnosis of acute
myocardial infarction or prior ICD in situ were excluded.
Results: From 1996 to 2001, 113,262 patients were admitted for SCD. Of those, 63,745
(56.3%) did not survive to hospital discharge. Of the remaining 49,517 patients, 30.7%
received an ICD prior to discharge, with a gradual increase in implantation rates from
1996 (23.6%) to 2001 (46.3%). Using logistic regression, patients who were discharged
without an ICD were older (OR=1.15 for every 10 year increase in age, P<0.001), more
likely to be women (OR=1.76, p<0.001) or of African American race (OR=17.14,
p<0.001), and more likely to be admitted to a smaller hospital (OR=0.41 for each addi-
tional 100 beds, P<0.001).
Conclusions: Though increasing, rates of ICD implantations after SCD remain very low.
There are gross discrepancies by race and gender in the utilization of the ICD. At a time
when newer indications for ICD implantation are emerging, efforts should be focused on
identifying the causes of this underutilization and discrepancies in survivors of SCD.
1147-214 Wide WRS Increases Risk From Right Ventricular 
Pacing
John J. Hayes, John M. Herre, Beverly Firth, Anna O. Leonen, Alfred Hallstrom, The 
DAVID Trial Investigators, Marshfield Clinic, Marshfield, WI
Background: An increasing number of studies have shown adverse effects from the dys-
synchrony associated with right ventricular (RV) pacing. The DAVID Trial found an
increased risk of the combined endpoint of death and hospitalization for new or worsen-
ing CHF in ICD patients paced DDDR-70 bpm versus VVI-40 bpm. Patients in the DDDR
arm were paced 59% of the time and VVI patients were paced 4%. We sought to deter-
mine whether baseline QRS duration was an indicator of increased risk in this trial.
Methods: Subgroup analysis was carried out on DAVID Trial patients defining wide QRS
(WQRS) as >130 ms. and narrow QRS (NQRS) as <130ms. Time to primary endpoint
was analyzed using the Kaplan-Meier method and Cox stepwise regression.
Results: There were 346 pts. with NQRS and 153 pts. with WQRS. The one year event
rate in NQRS patients was 20% in DDDR and 16% in VVI (p=0.526). In WQRS the rates
were 39% in DDDR and 15% in VVI (p=0.012). Stepwise regression indicated a signifi-
cant interaction between therapy arm and QRS duration (p=0.022).
The relative risk of the primary endpoint was: 
Conclusion: This post hoc analysis suggests patients with a QRS duration >130ms. are
at an increased risk of the adverse effects of RV pacing compared to those with a narrow
QRS. NQRS and WQRS ICD patients had similar event rates when not paced (VVI-40
bpm). Further studies will be required to verify these findings.
1147-215 Soft Indications for Pacing in the DAVID Trial Do Not 
Increase Mortality and Heart Failure Admission
Steven P. Kutalek, Arjun Sharma, Alfred Hallstrom, Leon Greene, Jeffrey Neuhauser, 
Kerry Schwartz, Marc Roelke, Marianne Anderson, Karen Belco, Anna Leonen, and the 
DAVID Investigators, Drexel University College of Medicine, Philadelphia, PA, University 
of Washington, Seattle, WA
Background: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial demon-
strated an increased frequency of combined heart failure (HF) and mortality for defibrilla-
tor patients (pts) paced in the DDDR mode vs. those with backup VVI pacing. Although
no pts enrolled in the DAVID trial strictly required bradycardia pacing, some had soft indi-
cations. We postulated that these pts would utilize more right ventricular pacing and have
an increase in endpoints of HF and mortality compared to pts without such criteria.
Methods: Pts enrolled in the main trial were stratified into no firm indications for pacing
(NoI, n=378) and soft indications (SoI, n=121), namely sinus rate < 60 bpm and/or first
degree AV block with LBBB. Groups were analyzed with respect to endpoints.
Results: There was no difference in baseline characteristics between NoI and SoI,
including age (64 v 67 yrs), ejection fraction (27 v 28%), history of HF, coronary disease,
or index ventricular arrhythmia. These groups had no difference in time to first recurrent
arrhythmia or to the combined endpoint of death or first hospitalization for HF. There was
a trend toward increased HF hospitalization for NoI pts (p=0.07), even though frequency
of pacing was higher in the SoI group. At 3-months, pacing frequency between NoI and
SoI was 51.0% v 74.4% (p=0.001) in the atrium and 26.4% v 39.1% (p=0.008) in the ven-
tricle.
There was no difference in time to first recurrent arrhythmia between pts with SoI paced
VVI v DDDR, although cumulative mortality tended to be greater in the DDDR group
(one-year event rates of 2.9% vs. 11.9%, p=0.09).
Hospital Size (# of beds) 6-99 100-199 200-299 300-499 500+
% of Patients Receiving ICD 0 14.2 30.8 49.2 56.2
DDDR vs VVI
WQRS 2.6
NQRS  0.9
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Independent of pacing indication, pts with LBBB had a significantly higher HF/mortality
endpoint when paced DDDR v VVI (p=0.03). There was no significant difference in those
without LBBB.
Conclusions: The presence of SoI for pacing in defibrillator pts does not affect arrhyth-
mia recurrence or the combined endpoint of death or HF, although pts with NoI tend to
have increased HF admissions. DDDR pacing dramatically increases the HF/mortality
endpoint in pts with LBBB, mimicking main trial results.
1147-216 Electrosurgical Dissection for Extraction of Chronically 
Implanted Pacemaker and Defibrillator Leads
Muhammad F. Jan, Manoj M. Panday, Tanveer Padder, Christine Saari, Farooq Padder, 
Steven P. Kutalek, Hahnemann University Hospital, Drexel University College of 
Medicine, Philadelphia, PA
Background: The major hurdle in the extraction of chronically implanted leads is their
fibrotic attachment to the vascular and cardiac structures. Mechanical devices, such as
locking stylets and telescoping non-powered sheaths, are effective but may not pass
through dense fibrosis. Laser sheaths can dissect areas of heavy non-calcified fibrosis,
though not without complications from circumferential lesions. The electrosurgical dis-
section sheath (EDS), the newest addition to powered sheaths for lead extraction, allows
directional, non-circumferential delivery of radiofrequency energy to ablate fibrotic tissue.
There currently remains a lack of evidence to support the efficacy and safety of the EDS
for lead extraction.
Methods: Data from 56 consecutive patients (67 ± 15 years of age) requiring lead
extractions at our institution was prospectively collected. The EDS (Cook Vascular) was
used to extract 80 chronically implanted leads. The average duration of implantation was
8.2 years; 95% of the patients had pacemaker leads, and 5% of the patients had defibril-
lator leads. Patients were followed up at one and six weeks post-procedure for detection
of any post-operative or late complications.
Results: 78 of 80 leads (97.5%) were completely extracted; the two incompletely
extracted leads were in the same patient. The mean time required to achieve a success-
ful lead extraction was 22.5 ± 17.2 minutes from the time the lead was cut until its
removal. A total of five patients (8.9%) had intra-operative complications including two
patients with bleeding at the operative site requiring transfusion, one flail tricuspid valve
leaflet without hemodynamic sequelae, one hemopericardium requiring pericardiocente-
sis, and one hemothorax from a SVC tear which resulted in death after an emergent tho-
racotomy was performed.
Conclusion: In patients with a long duration of pacemaker or defibrillator implantation,
the use of the EDS to assist lead extraction results in a high success rate with an accept-
able procedure time. The advantage of this device lies in its ability to selectively dissect
areas of heavy fibrosis; however, the risk of complications remains similar to that of other
powered sheaths.
1147-217 Do Abandoned Leads Pose Risk to Implantable 
Defibrillator Patients?
Marjorie L. Martin, Michael Glikson, David O. Hodge, Amy L. Beeman, Win K. Shen, 
Samuel J. Asirvatham, Robert F. Rea, David L. Hayes, Stephen C. Hammill, Paul A. 
Friedman, Mayo Clinic, Rochester, MN, Sheba Medical Center, Tel Hashomer, Israel
Background: Due to lead failure or upgrade from pacemaker (PM) to defibrillator (ICD),
implanters often face the dilemma of choosing whether to extract or cap old leads. Argu-
ments supporting removal include the risk of electrical noise, increased defibrillation
threshold or venous thrombosis caused by unused leads. We sought to determine the
rate of these complications in patients (pts) with abandoned leads.
Methods and Results: We retrospectively reviewed the prospectively collected Mayo
Clinic ICD database.Pts (n=64) were found to have 108 leads capped between 10/94 and
12/01. The following types of leads were capped: epicardial (n=6 pts, 9%) endocardial
(52, 81%), both (5, 8%), or SQ patch only (1, 2%). Abandoned leads were right ventricu-
lar ICD (n=27), RV pacing (26), SVC coil (12), CS coil (1), right atrial pacing lead (12),
epicardial patch (15), epicardial pace/sense (11), and subcutaneous patches (4). Rea-
sons for capping included lead defect (fracture or insulation break) in 47 pts, elevated
defibrillation threshold in 9, upgrading from PM to ICD in 30, upgrading from epicardial to
transvenous system in 9, upgrading to an active-can ICD in 5, and other in 8. Newly
placed leads were true bipolar sensing in 19/63 (30 %) of cases, and active fixation in 52/
63.
With a mean follow up of 25 ± 16 months after capping, 1 pt developed pocket stimula-
tion, and 1 pt developed T wave oversensing; there were no other complications. Before
capping 11 pts had received inappropriate shocks; no patients received them post cap-
ping. DFTs before and after lead capping were 13 ± 7 J (n=42 pts) and 14 ± 5J (n=64),
respectively (p=NS).
Conclusions: Complications in ICD systems following capping of unused leads are
uncommon. Capping rather than extraction of unused leads can often be safely consid-
ered.
1147-218 Pocket Cleaning With Povidone-Iodine Does Not 
Reduce the Infection Rate of Implantable Pacemakers 
and Defibrillators
Dhanunjaya Lakkireddy, S. Valasareddi, X. Shen, H. Korlakunta, H. Li, S. Mohiuddin, 
Creighton University, Omaha, NE
Background: Infection is a devastating complication of implantable pacemakers/ defibril-
lators. Povidone-iodine is a fast-acting, broad-spectrum antiseptic used for cleaning of
the skin, wounds and mucous membranes. Many physicians also use the Povidone-
iodine solution to wash the pacemker/defibrillator pockets during the implant procedure.
Whether the use of Povidone solution in the sterile environment of the pacemaker/
defibrillator pockets have any impact on the pocket infection rate is unknown. Methods &
results: Of the total of 2564 patients undergoing implantable devices between 1994 and
2002, 53% had the device pocket washed with Povidone-iodine solution (Group I) and 47
% had the device pocket washed with saline only (Group II). A total of 18 patients (0.7%)
had infection of the device pocket, 10 (0.7%, 10/1359) in the Group I and 8 (0.6%, 8/
1205) in Group II. There was no significant difference in gender (male/female, 63%/37%
vs 60%/40%) and the type of devices (pacer/defibrillator 38%/ 62% vs 40%/60%), age
(69 ±14 vs 68±16 years, p=ns), diabetes mellitus (25% vs 20%, p=ns), renal insufficiency
(0 vs 10%, p=ns), abnormal urine analysis (29% vs 40%, p=ns), oral temperature
(98.2±1.2 vs 97.7±1.0 oF, p=ns), white cell count (7±2 vs 9±3 thousand/ml, p=ns), dura-
tion of procedure (37±7 vs 45±10 minutes, p=ns), median time to infection from implanta-
tion (40 vs 22 days, p=ns) between Group I and II. All patients in both groups received
pre-implantation antibiotics. All patients in Group-II but none in Group-I received post-
implantation antibiotics (p=0.03). Conclusion: Povidone-iodine wash of the device
pocket does not affect the rate of pocket infection in centers with low infection rate.
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1148-207 Quantification of Atrial Fibrillation Organization From 
the Surface Electrocardiogram
Daniela Husser, Martin Stridh, Leif Soernmo, Bertil Olsson, Christoph Geller, Helmut U. 
Klein, Andreas Bollmann, Otto-von-Guericke University, Magdeburg, Germany, Lund 
University, Lund, Sweden
Background: The dominant atrial fibrillatory rate obtained from the surface ECG during
atrial fibrillation (AF) has recently been suggested to reflect atrial refractoriness and to
predict responses to antiarrhythmic drugs and electrical cardioversion. More recently,
time-frequency analysis (TFA) taking atrial rate variability and AF organization into
account, has been developed. This study explored the potential value of TFA for (1) mon-
itoring antiarrhythmic drug action and (2) predicting AF recurrence following cardiover-
sion.
Methods and Results: Baseline two-minute ECG recordings were made in 44 consecu-
tive patients (26 male, 18 female, mean age 62±11 years with persistent AF. After spa-
tiotemporal QRST cancellation, TFA was performed and the following parameters were
determined: (1) averaged instantaneous rate, (2) stability of the instantaneous second-to
second rate expressed as the segment proportion with consecutive rate differences <6
fibrillations per minute (fpm), and (3) amplitudes of fundamental and harmonic frequency
components expressed as exponential decay (γ). Measurements were repeated three
days after oral amiodarone (1200 mg/d), flecainide (200 – 300 mg/d) or sotalol (240 mg/
d) was initiated. Drug loading organized AF as expressed by (1) atrial rate decrease
(400±77 vs. 322±52 fpm), rate stability increase (12±3 vs. 31±22 %), and γ decrease
(1.3±0.2 vs. 0.9±0.3; p<.001 for all variables). γ correlated with averaged rate (R=.378,
p=.01; R=0.763, p<.001) and rate stability (R=-.437, p=.003; R=-.653, p<.001) at base-
line and after drug loading. Following restoration of sinus rhythm, AF recurred in 13
patients during 3 months follow-up. Those patients had a higher atrial rate (420±38 vs.
396±41 fpm, p=.05) and a larger γ (1.4±0.2 vs 1.1±0.2, p=.007) at baseline than patients
who remained in sinus rhythm. Multivariate regression analysis revealed γ (Beta=4.753,
p=.001) to be the only independent predictor for AF recurrence.
Conclusions: TFA allows quantification of atrial rate, its variability and AF organization.
This method has the potential to monitor individual antiarrhythmic drug responses and
predict outcome following cardioversion of AF patients.
1148-208 Psychological Stress Increases Heterogeneity of 
Repolarization in Patients With Structural Heart Disease 
and Ventricular Arrhythmias
Rachel Lampert, Vladimir Shusterman, Matthew M. Burg, Forrester A. Lee, Christine 
Earley, Anna Goldberg, Craig A. McPherson, William P. Batsford, Robert Soufer, Yale 
University School of Medicine, New Haven, CT, University of Pittsburgh, Cardiovascular 
Institute, Pittsburgh, PA
Background: Psychological stress can precipitate ventricular arrhythmias in patients
with ICDs, as well as sudden death. However, the physiologic pathways remain unknown.
We hypothesized that stress would increase heterogeneity of repolarization, known to be
arrhythmogenic.
Methods: 32 pts with ICDs and a history of ventricular arrhythmia underwent ambulatory
ECG monitoring during a laboratory mental stress protocol (anger recall and mental
arithmetic.) Continuous changes in repolarization indices known to be correlated with
myocardial dispersion of refractoriness, including T-wave alternans (TWA), T-wave ampli-
tude (Tamp), and T-wave area (Tarea), were analyzed in the time-domain. QT and mean
activation-recovery interval (MARI), a correlate of mean epicardial activation-recovery
time, were also measured.
Results: 27 pts had adequate holter recordings, 23 male, mean age 62 +/- 12 years, 23
with CAD, mean EF 32 +/- 10%, 24 on beta-blockers. Norepinephrine, BP, and HR
increased during mental stress. TWA increased, as did Tamp and Tarea. QT interval and
MARI decreased. TWA changes were greater during late repolarization (peak to end of
T.) (See table). Changes in TWA were associated with changes in HR, systolic BP, and
